Kanoria Chemicals & Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
KANORICHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kanoria Chemicals reported its audited standalone and consolidated results for FY25 with the board recommending no dividend. Standalone revenue from operations grew 17.6% to ₹67,830 lakhs (FY24: ₹57,686 lakhs), while consolidated revenue rose 4.2% to ₹1,53,671 lakhs. However, the company slipped into a standalone net loss of ₹3,798 lakhs (vs ₹112 lakh loss in FY24) and a consolidated net loss of ₹10,815 lakhs (vs ₹5,528 lakh loss). The losses were driven by exceptional items worth ₹4,499 lakhs on standalone (impairment of investments in subsidiaries Kanoria Africa Textiles PLC and APAG Holding AG) and ₹2,944 lakhs goodwill impairment on consolidated. The Solar Power Division was classified as discontinued operations following its slump sale. Auditor Singhi & Co. issued an unmodified opinion on both sets of results.
Shareholders see no dividend and a significant bottom-line loss despite revenue growth, primarily due to one-time impairments in foreign subsidiaries, which may weigh on near-term sentiment though core operations show operating profit growth. The fresh impairments raise concerns about the value of overseas subsidiaries but are non-cash in nature.